The reason is that the only thing in these patients samples going to ipsc derived neurons are theirDNA
we know that autism is not a monogenic disorder.
it.s hard to believe that such a polygenic in nature could give rise to one criteria to differentiate patients from controls
of course if you use 1000 gene expression asylum matrix, you might be able to. Then you should just publish , it is useless in reality from screening point of view.